i doubt that HTBX will run like others because the gp96 vaccine is cell-based, it can’t be manufactured on a large scale and the big market players are well aware of that !
so they are addressing a small population with their vaccine which is only the elderly !
here is an article that explains it and i copied paste the part that cover the matter !
Since the gp96 vaccine is cell-based, it can’t be manufactured on a large scale. But we are not aiming for large distribution where everybody would get it. We’re going for the vulnerable populations, particularly the elderly and the immunosuppressed. The immune response in the elderly is definitely different than other age groups. And we think this approach, where we activate the natural immune response without the actual virus, could work well in people over 65. But the good thing about what is happening now is that we are all learning from each other. The whole world is a big laboratory; and now more than ever, it’s important that we share information as soon as possible so we can adapt the vaccine when needed. It’s a new virus and we don’t know much about it. So how are we going to fight it if we don't know what it does?
News 
Market Data 
Discover 
